The SARAH domain at the C-terminus of human MST2 (residues 436-484) was overproduced and purified using an Escherichia coli expression system. The purified domain was crystallized using the hanging-drop vapour-diffusion technique. Two crystal forms were obtained. The crystals belonged to space group P2, with unit-cell parameters a = 62.0, b = 119.2, c = 62.0 Å , = 90.0, = 90.5, = 90.0 , or to space group P6 1 22, with unit-cell parameters a = 54.5, b = 54.5, c = 303.1 Å . These crystals diffracted to 2.7 and 3.0 Å resolution, respectively.
Introduction
Mammalian sterile 20-like kinases 1 and 2 (MST1 and MST2) are core components of the Hippo signalling pathway, which plays a crucial role in cell proliferation and apoptosis (Wu et al., 2003) . MST1 and MST2 share 78% sequence identity (Creasy & Chernoff, 1995) . MST kinase activity can be regulated by caspase cleavage of the C-terminal inhibitory domain (Graves et al., 1998) , resulting in translocation of the kinase domain to the nucleus. In response to apoptotic stress, MSTs can induce phosphorylation of histone H2B and activation of JNK, leading to chromatin condensation, DNA fragmentation and apoptosis (Bao et al., 2011) . Autophosphorylated MST1/2 interacts with Salvador (Sav)/WW45 for translocation into the nucleus to activate LATS1/2 (Chan et al., 2005) , which results in the downregulation of transcription factors via phosphorylation and inactivation of YAP (the transcription coactivator yes-associated protein). YAP has been shown to play a key role in mediating cellcontact inhibition, organ size and tumourigenesis (Zhao et al., 2007) . The C-terminal region of MST1/MST2 contains a SARAH (Sav/ RASSF/Hippo) domain that interacts with the corresponding SARAH domain of WW45 (Callus et al., 2006) . The SARAH domain mediates a heterotropic interaction that transmits the signal from MSTs through the scaffolding protein WW45 to the downstream component LATS1/2 (Scheel & Hofmann, 2003) . In addition, MST1/2 dimerize via the SARAH domain (Creasy et al., 1996) and the autoactivation of MST1 is inhibited by removal of the SARAH domain (Lee et al., 2008) . Thus, SARAH-mediated homodimerization and heterodimerization induces apoptosis and suppresses cell-cycle progression (Scheel & Hofmann, 2003) .
A previous study of the solution structure of the human MST1 SARAH domain revealed its homodimeric structure and its heterotropic interaction with the Rassf5 and WW45 SARAH domains (Hwang et al., 2007) . To identify structural features of the MST2 SARAH domain and provide further information on the molecular mechanisms of the Hippo pathway, we performed the overproduction, purification, crystallization and preliminary X-ray diffraction data analysis of the MST2 SARAH domain.
Materials and methods

Cloning, overproduction and purification
The cDNA coding the MST2 SARAH domain (residues 436-484) was subcloned into a modified pGEX4T1 vector (GE Healthcare, USA) containing an N-terminal GST tag and a tobacco etch virus (TEV) protease-cleavage site. The nucleotide sequence was verified by DNA sequencing. The resulting construct was transformed into Escherichia coli BL21 (DE3) strain for protein overproduction. The transformed cells were cultured in LB medium containing 100 mg ml À1 ampicillin at 310 K until the OD 600 reached 0.5-0.6. Target-protein overproduction was then induced by incubating the cells with 0.3 mM IPTG at 291 K for 16 h. The cells were harvested by centrifugation at 6000g for 15 min at 277 K and resuspended in binding buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl) containing 0.1% Triton X-100 and 10 mM -mercaptoethanol. The cells were sonicated on ice, the lysate was collected by centrifugation at 18 000g for 40 min at 277 K and the pellet was discarded. The supernatant was loaded onto a gravity-flow column (Bio-Rad, USA) packed with 3 ml Glutathione Sepharose 4B resin (GE Healthcare) and the resin was extensively washed with binding buffer. Proteins were eluted from the resin with elution buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM reduced glutathione). The fusion protein was cleaved overnight with TEV protease at 293 K and then concentrated to 3 ml using a 5 kDa cutoff membrane (Amicon Ultra-15 filter, Millipore, USA). Size-exclusion chromatography was performed using HiLoad 16/60 Superdex 200 (GE Healthcare) pre-equilibrated with wash buffer (20 mM Tris-HCl pH 8.0, 50 mM NaCl, 1 mM DTT, 10% glycerol). The purified protein was concentrated to 10 mg ml À1 using a 5 kDa cutoff membrane (Amicon Ultra-15 filter, Millipore, USA).
Crystallization and X-ray data collection
Initial conditions for crystallization were screened at 293 K by the hanging-drop vapour-diffusion technique using a PEG screening kit from our laboratory which was designed for the crystallization of protein-protein complexes. Protein solution (1 ml) was mixed with reservoir solution (1 ml) and equilibrated against 400 ml reservoir solution. Data sets were collected using a Rayonix MX-225HE CCD detector supported by NSRRC on the BL44XU beamline at SPring-8 (Harima, Japan). The diffraction data were indexed, integrated, scaled and merged using HKL-2000 (Otwinowski & Minor, 1997) .
Results and discussion
The human MST2 SARAH domain was overproduced and purified to homogeneity (approximately 95% purity) using Glutathione Sepharose 4B and Superdex 200 columns. The protein was concentrated to 10 mg ml À1 for crystallization trials. Crystals were obtained using many different initial conditions. Crystallization conditions were optimized by changing the concentrations of various salts at 293 K. Crystals diffracting to 2.7 Å resolution were obtained using a reservoir solution consisting of 20%(m/v) PEG 3350, 1 M urea and 0.1 M Tris-HCl pH 7.4. The crystals belonged to space group P2, with unit-cell parameters a = 62.0, b = 119.2, c = 62.0 Å , = 90.0, = 90.5, = 90.0 . Assuming the presence of eight molecules as dimers in the asymmetric unit, the Matthews coefficient (V M ) and solvent content were calculated as 2.5 Å 3 Da À1 and 50.8%, respectively (Matthews, 1968) . Another crystal form was obtained from a solution consisting of 10%(m/v) PEG 3350, 0.1 M ammonium phosphate and 0.1 M Tris-HCl pH 7.4 (Fig. 1) . The crystals diffracted to 3.0 Å resolution and belonged to space group P6 1 22, with unit-cell parameters a = 54.5, b = 54.5, c = 303.1 Å (Fig. 2) . Assuming the presence of two molecules as a dimer in the asymmetric unit, the V M value was 2.84 Å 3 Da À1 Hwang et al., 2007) . Unfortunately, no solution could be found.
The solution structure of the MST1 SARAH domain was reported to be a homodimer (Hwang et al., 2007) . Based on our size-exclusion chromatography results, the molecular mass of the purified MST2 SARAH domain was estimated to be 23 kDa, which corresponds to a tetramer (data not shown). Therefore, we wondered whether a tetrameric form of the protein could be observed in the X-ray structure. Hence, determination of the crystal structure of the MST2 SARAH domain could provide further information about the mechanism underlying heterotropic interactions in the Hippo pathway facilitated by SARAH domains. We have prepared selenomethionine-labelled crystals in order to solve the phase problem using anomalous dispersion techniques.
